PE
ETNB

Point72 Europe’s 89bio ETNB Stock Holding History

Point72 Europe’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.78K Buy
+393
New +$4.01K ﹤0.01% 587

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Europe's ETNB Position: Q3 2025 in Review

Point72 Europe opened a new position in 89bio (ETNB) in Q3 2025: 393 shares worth $5.78K. The stake represents ﹤0.01% of the portfolio and ranks #587 among its holdings.

198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Point72 Europe held 393 shares of 89bio worth $5.78K as of Q3 2025.
  • 89bio was a new Point72 Europe position in Q3 2025.
  • 89bio made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #587 holding.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.